From: Novel targets for potential therapeutic use in Diabetes mellitus
Compound | Class | Mode of action | Potential role in diabetes | References |
---|---|---|---|---|
11β Hydroxysteroid dehydrogenase | Glucocorticoids | High levels cause glucose intolerance | By inhibiting 11β-HSD Decrease in blood glucose levels, improved insulin sensitivity | [55] |
ACRP-30 | Hormone | Low levels cause insulin sensitivity | Increase in Acrp30 will increase the insulin sensitivity and decrease in blood glucose levels | |
FETUIN-A | Glycoprotein | Involved in the inflammation of the β-cells | Low levels of Fetuin-A will increase the insulin sensitivity | [59] |
VISFATIN | Protein | Attaches to the insulin receptor | Insulin-mimetic action | [60] |
METRNL | Adipokine | Cause up regulation of the PPARγ pathway | Increase in the insulin sensitivity | [61] |
PEDF (Pigment epithelium-derived factor) | Glycoprotein | Increase kinase-mediated Serine/Threonine phosphorylation cascade of IRS which causes insulin resistance | Decreasing level of PEDF increases the insulin sensitivity | [64] |
VASPIN (SERPIN A12) | Serum glycoprotein | Vaspin performs its action by inhibiting the KLK7 | Due to inhibition of KLK7, insulin signalling is improved and also the half-life of insulin is increased that helps in decreasing the blood glucose levels | |
GPER (G protein-coupled estrogen receptor) | Glycoprotein | Regulation of glucose homeostasis by binding to both Gi/o and Gs proteins | Increase insulin secretion | |
GENE THERAPY | Gene | Act by correcting or repairing the defective genes | Suppression of auto reactive T cells to stop islet cells destruction |